Dr. Peter McCullough, alongside other distinguished medical scientists and physicians, recently filed a lawsuit directed against the U.S. Food and Drug Administration (FDA) to access the data the federal agency “relied upon” to grant the pharmaceutical giant its COVID-19 vaccine license.
McCullough and his group, the Public Health and Medical Professionals for Transparency (PHMPT), filed the suit because, despite the irregularities with the experimental mRNA vaccine manufactured by Pfizer, its license was still given the green light by the FDA.
The legal action was also filed because the FDA seems to take no notice of the still-rising incidents of vaccine-related injuries that have occurred ever since the roll-out of the shots began. Apart from heart problems like myocarditis and pericarditis, other adverse side effects that have been observed after getting the COVID-19 jabs include pulmonary embolism, brain tumors, renal failure, deep vein thrombosis, and even sudden death.
Reports have even been raised to the Vaccine Adverse Event Reporting System (VAERS) that the COVID-19 vaccine caused reproductive issues in some women like spontaneous abortion, ovarian problems, and stillbirth.
Besides the esteemed cardiologist, Dr. Peter McCullough, the PHMPT is also composed of other big names like Dr. Aaron Kheriaty, the Medical Ethics Director of the University of California, and Dr. Harvey Risch, an epidemiologist from Yale.
The said lawsuit was filed with the United States Court North District of Texas, and its primary objective is to review the data and information that led to the FDA’s approval of Pfizer’s COVID-19 vaccine.
“Reviewing this information will settle the ongoing public debate regarding the adequacy of the FDA’s review process,” one of the crucial paragraphs of the lawsuit contended. “Releasing this data should also confirm the FDA’s conclusion that the Pfizer vaccine is safe and effective.” The suit also argued that if the data and information are released to the public, it will result in higher confidence in the shots.
McCullough and his fellow PHMPT advocates also reminded that since the FDA is a federal agency, the public has the right to access its data under the Freedom of Information Act.
Aaron Siri, the PHMPT’s lawyer, stressed a crucial need for transparency on the matter at hand. And this transparency is not something that should be withheld from the people. “Scientists, health care professionals, and every person in this country, especially those mandated to receive this product, should have access to the data now,” he pointed out.